Takeda Settles With Irish Revenue Over Shire Break Fee

Takeda Pharmaceutical says it agreed with the Irish Revenue Commissioners to settle a tax assessment on a acquisition break fee received by Shire in Oct. 2014.

• Company will pay €130m, resulting in a tax expense reduction of ~63b yen as it will reverse previously recorded provisions
• Will announce any revision to full-year forecast in earnings call on Oct. 26

To view the source of this information, click here

To contact the reporter on this story:
Gareth Allan in Tokyo at gallan11@bloomberg.net

To contact the editors responsible for this story:
Yusuke Miyazawa at ymiyazawa3@bloomberg.net

Ryotaro Nakamaru

© 2023 Bloomberg L.P. All ...